A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02116569 · COMPLETED
Trial details
- NCT number
- NCT02116569
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-09-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.